Trademark Overview
On Tuesday, March 10, 2026, a trademark application was filed for ANIMUNE-Q with the United States Patent and Trademark Office. The USPTO has given the ANIMUNE-Q trademark a serial number of 99693605. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, March 10, 2026. This trademark is owned by Q-VANT Biosciences, Inc.. The ANIMUNE-Q trademark is filed in the Pharmaceutical Products category with the following description:
Vaccine preparations; Vaccine adjuvants; Human vaccine preparations; Oral vaccine preparations; Adjuvants for medical purposes; Adjuvants for use with vaccines; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the prevention and treatment of cancer; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Plant extracts for pharmaceutical purposes...
